Forecast & Rating2 analysts currently cover P3 Health Partners, of which 1 give a positive rating. The average price target is $18.00, about 95.2% upside from the current price of $9.22. Coverage is limited, so the data is for reference only. Data as of Aug 26, 2026; this does not constitute investment advice.
Aug 26, 2026Price forecast
$18.0095.23%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy0.00%
- Hold50.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met27.1%
Stock price$9.22
Avg. target$10.3
High target$13
Low target$8
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.